Extracellular Matrix Cell News Volume 11.44 | Nov 12 2020

    0
    54







    2020-11-12 | ECM 11.44


    Extracellular Matrix News by STEMCELL Technologies
    Vol. 11.44 – 12 November, 2020
    TOP STORY

    Activating
    an Adaptive Immune Response from a Hydrogel Scaffold Imparts Regenerative Wound Healing

    The authors demonstrated that the generation of an adaptive immune response from a biomaterial is sufficient to induce cutaneous regenerative healing despite faster scaffold degradation.
    [Nature Materials]

    AbstractPress Release


    View tips on how to choose efficient technologies for your research.
    PUBLICATIONSRanked by the impact factor of the journal

    Netrin
    G1 Promotes Pancreatic Tumorigenesis through Cancer Associated Fibroblast Driven Nutritional Support and Immunosuppression

    Scientists found that Netrin G1 (NetG1)+ cancer-associated fibroblasts (CAFs) support pancreatic ductal adenocarcinoma survival, through a NetG1 mediated effect on glutamate/glutamine metabolism. NetG1+ CAFs were intrinsically immunosuppressive and inhibited NK cell mediated killing of tumor cells.
    [Cancer Discovery]

    Abstract

    Senescence
    Reprogramming by TIMP1 Deficiency Promotes Prostate Cancer Metastasis

    Researchers identified the metalloproteinase inhibitor TIMP1 as a molecular switch that determines the effects of senescence in prostate cancer. Senescence driven either by PTEN deficiency or chemotherapy limited the progression of prostate cancer in mice.
    [Cancer Cell]

    AbstractGraphical Abstract

    Shape-Shifting
    Peptide Nanomaterials: Surface Asymmetry Enables pH-Dependent Formation and Interconversion of Collagen Tubes and Sheets

    Investigators describe the design and synthesis of crystalline supramolecular architectures from charge-complementary heteromeric pairs of collagen-mimetic peptides.
    [Journal of the American Chemical Society]

    Abstract

    Biomaterial-Based Scaffold for In Situ
    Chemo-Immunotherapy to Treat Poorly Immunogenic Tumors

    The authors describe a general strategy for in situ cancer vaccination that exploited both the immunogenic death of tumor cells and dendritic cell recruitment by biomaterial scaffolds. The strategy controled 4T1 tumor growth and reduced metastases with minimal systemic toxicity, potentially providing a potent therapeutic option for triple negative breast cancers.
    [Nature Communications]

    Full ArticlePress Release

    A Reactive Oxygen Species Scavenging and O2
    Generating Injectable Hydrogel for Myocardial Infarction Treatment In Vivo

    In this study, a novel type of injectable hydrogel with dual functions of reactive oxygen species scavenging and O2 generation was fabricated for myocardial infarction treatment, in vivo.
    [Small]

    Abstract

    Mechanically
    Superior Matrices Promote Osteointegration and Regeneration of Anterior Cruciate Ligament Tissue in Rabbits

    Scientists illustrate the beneficial effect bioactive factors and polyethylene terephthalate incorporation have on anterior cruciate ligament (ACL) regeneration and signal a promising step toward the clinical translation of a functional bioengineered ACL matrix.
    [Proceedings of the National Academy of Sciences of the United States of America]

    Abstract

    Targeted
    Deletion of CXCR2 in Myeloid Cells Alters the Tumor Immune Environment to Improve Antitumor Immunity

    Recruitment of myeloid-derived suppressor cells into the tumor microenvironment contributes to cancer immune evasion. Researchers compared the growth and metastasis of melanoma and breast cancer xenografts in mice exhibiting or not exhibiting targeted deletion of Cxcr2 in myeloid cells.
    [Cancer Immunology Research]

    Abstract

    Prrx1
    Fibroblasts Represent a Pro-Fibrotic Lineage in the Mouse Ventral Dermis

    Scientists demonstrated that paired related homeobox 1 (Prrx1)-expressing fibroblasts were responsible for acute and chronic fibroses in the ventral dermis.
    [Cell Reports]

    Full ArticleGraphical Abstract

    Exosomal
    miR-590-3p Derived from Cancer-Associated Fibroblasts Confers Radioresistance in Colorectal Cancer

    High expression of miR-590-3p and low expression of CLCA4 was found in both colorectal cancer (CRC) tissues and cell lines. CLCA4 was indicated as a target gene of miR-590-3p. CAF-derived exosomes were extracted and co-cultured with CRC cells which were then exposed to radiation.
    [Molecular Therapy-Nucleic Acids]

    AbstractGraphical Abstract
    Full Article

    Stromal
    Microenvironment Promoted Infiltration in Esophageal Adenocarcinoma and Squamous Cell Carcinoma: A Multi-Cohort Gene-Based Analysis

    Investigators proposed a practical classifier for the stromal microenvironment to predict the prognosis of esophageal carcinoma patients.
    [Scientific Reports]

    Full Article

    Probing
    Coordinated Co-Culture Cancer Related Motility through Differential Micro-Compartmentalized Elastic Substrates

    To study coordinated cell motility with localized elasticity substrates, scientists fabricated a substrate with localized alternating elasticities to control the mechanical microenvironment of cells.
    [Scientific Reports]

    Full Article

    Membrane-Type
    1 Matrix Metalloproteinase Modulates Tissue Homeostasis by a Non-Proteolytic Mechanism

    Membrane-type 1 matrix metalloproteinase (MT1-MMP, MMP-14), a transmembrane proteinase with a short cytoplasmic tail, is a major effector of ECM remodeling. The authors provide the first in vivo demonstration that MT1-MMP modulates bone, cartilage and fat homeostasis by controlling skeletal stem cell differentiation through a mechanism independent of proteolysis.
    [iScience]

    AbstractGraphical Abstract
    Full Article


    Connect with us via LiveChat to ask your scientific support questions
    REVIEWS

    Eph
    Receptors in the Immune-Suppressive Tumor Microenvironment

    The tumor microenvironment (TME) promotes tumor development via complex intercellular signaling, aiding tumor growth and suppressing immunity. Eph receptors and their ephrin ligands control cell interactions during normal development, and re-emerge in tumors and the TME, where they are implicated in invasion, metastasis and angiogenesis.
    [Cancer Research]

    Abstract

    Patient-Derived Tumor Models for Personalized Therapeutics in Urological Cancers

    Preclinical knowledge of dysregulated pathways and potential biomarkers for urological cancers has undergone limited translation into the clinic. Moreover, the low approval rate of new anti-cancer drugs and the heterogeneous drug responses in patients indicate that current preclinical models do not always reflect the complexity of malignant disease.
    [Nature Reviews Urology]

    Abstract

    INDUSTRY AND POLICY NEWS

    FDA
    Grants a Breakthrough Device Designation for Spiderwort Spinal Cord Technology

    Spiderwort Inc. has announced that the US FDA has designated CelluBridgeTM, Spiderwort’s Spinal Cord Scaffold Implant, as a “Breakthrough Device”.
    [Spiderwort Inc.]

    Press Release


    Surface Oncology Announces FDA Fast Track Designation Granted by US Food and Drug Administration for SRF388 to Treat Liver Cancer

    Surface Oncology develop next-generation immunotherapies that target the tumor microenvironment. They have announced that the US FDA has granted Fast Track designation to SRF388 for the treatment of patients with hepatocellular carcinoma who have been previously treated with standard therapies.
    [Surface Oncology]

    Press Release

    An
    Agenus-Discovered First-in-Class ILT4 Antibody, MK-4830, Enters Phase II

    Agenus Inc. announced that a milestone payment of $10M from Merck has been triggered with the advancement of an ILT4 antibody, MK-4830, into a Phase II clinical trial. Agenus discovered this novel checkpoint antibody, designed to target immune-suppressive myeloid cells in the tumor microenvironment for the treatment of advanced solid tumors, and licensed the molecule to Merck.
    [Agenus Inc.]

    Press Release

    FEATURED EVENT

    The
    Evolving Tumor Microenvironment In Cancer Progression: Mechanisms and Emerging Therapeutic Opportunities

    January 9 – January 12, 2021
    Lake Buena Vista, Florida, United States


    > See All Events

    JOB OPPORTUNITIES

    Research Professional – Life Sciences

    Stanford University – Stanford, California, United States

    Research
    Technician – Spinal Cord Injury Research

    Edward Via College of Osteopathic Medicine – Blacksburg, Virginia, United States

    Postdoctoral Research Fellow – Cancer Biology

    Moores Cancer Center, UC San Diego – La Jolla, California, United States

    Postdoctoral Fellow – Cancer Immunology and Immunotherapy

    H. Lee Moffitt Cancer Center & Research Institute – Tampa, Florida, United States

    Postdoctoral Researcher – Stem Cells & Aging

    Zhejiang University – Zhejiang, China

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Science News Extracellular Matrix News
    Archives Contact Us
    Extracellular Matrix News Twitter